Compared with patients with moderately controlled glucose levels, diabetic patients who have heart failure and either too high or too low glucose levels may be at increased risk of death, according to a retrospective study published online July 17 in the Journal of the American College of Cardiology.

Baxter International has reported strong financial results for the second quarter of 2009, causing the company to raise its third quarter financial outlook.

Merck and Schering-Plough, along with their joint venture, Merck/Schering-Plough Pharmaceuticals, have reached a civil settlement of $5.4 million with a group of attorneys general representing 35 states and Washington, D.C., who investigated whether the companies violated state consumer protection laws in connection with the ENHANCE trial or by their promotion and marketing of Vytorin and Zetia.

Aurobindo Pharma has received approval from the FDA for Fosinopril Sodium and hydrochlorothiazide (HCT) tablets, a generic equivalent of Bristol-Myers Squibb's ACE inhibitor Monopril HCT.

The FDA this afternoon approved Daiichi Sankyo and Eli Lilly's Effient (prasugrel) tablets for the reduction of thrombotic cardiovascular events, including stent thrombosis, in patients with acute coronary syndromes who are managed with PCI.

Emergency information is just one touch away with the American Heart Association's new Pocket First Aid & CPR application for the Apple iPhone, released July 9.

European prices of 170 best selling drugs averaged 40 percent less than U.S. prices in 2008, according to new research from healthcare market research firm Decision Resources.

Its increasingly clear that improved outcomes after an out-of-hospital cardiac arrest depend on having a host of protocols in place, rather than relying on one therapy or benchmark. Heres a look at automated CPR devices in the treatment of sudden cardiac arrest.